China Resources Double-Crane Pharmaceutical (SHA:600062) subsidiary Tiandong Pharmaceutical obtained listing approval of China's medical products administrator for its heparin sodium active pharmaceutical ingredient.
Heparin sodium is an anticoagulant used for preventing and treating blood clots, according to a Thursday filing with the Shanghai bourse.